The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).

BACKGROUND: Many men receive 5-alpha reductase inhibitors (5ARIs) for ongoing treatment of benign prostatic hyperplasia (BPH). The increased risk of cardiovascular complications with 5ARIs has been documented in BPH studies and the occurrence of cerebral venous thrombosis, presumably due to increase...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayodele, Olulade, Cabral, Howard J, McManus, David, Jick, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349190/
https://www.ncbi.nlm.nih.gov/pubmed/34377032
http://dx.doi.org/10.2147/CLEP.S317019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349190/
https://www.ncbi.nlm.nih.gov/pubmed/34377032
http://dx.doi.org/10.2147/CLEP.S317019

Ejemplares similares